Atrovent hfa and Zopiclone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent hfa (ipratropium bromide) and Zopiclone (eszopiclone). Common drug interactions include sinusitis among females and haemoptysis among males.

The phase IV clinical study analyzes what interactions people have when they take Atrovent hfa and Zopiclone. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Atrovent hfa?

Atrovent hfa has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 2,440 Atrovent hfa users. Check the latest studies of Atrovent hfa.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,330 Zopiclone users. Check the latest studies of Zopiclone.



On Jul, 14, 2026

24 people who take Atrovent hfa and Zopiclone together, and have interactions are studied.

Atrovent hfa and Zopiclone drug interactions.

What are the common drug interactions of Atrovent Hfa and Zopiclone, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Atrioventricular block first degree (heart block first degree)
  3. Cardiac fibrillation (uncontrolled muscle contraction of heart)
  4. Cardiac output decreased
  5. Crush injury (compression of extremities or other parts of the body that causes muscle swelling and/or neurological disturbances)
  6. Electrocardiogram qt prolonged
  7. Haematoma (collection of blood outside the blood vessels)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Malignant melanoma in situ (early stage of cancer in melanocyte)
  10. Road traffic accident

male:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  3. Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
  4. Infusion site pain
  5. Infusion site pruritus (severe itching at infusion site)
  6. Lung disorder (lung disease)
  7. Multiple allergies (allergy to multiple agents)
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  9. Anxiety
  10. Apathy

What are the common drug interactions of Atrovent Hfa and Zopiclone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  3. Peripheral swelling
  4. Rhonchi (abnormal breath sounds)
  5. Dyspnoea (difficult or laboured respiration)
  6. Atrioventricular block first degree (heart block first degree)
  7. Electrocardiogram qt prolonged
  8. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  9. Pain
  10. Pancreatitis (inflammation of pancreas)

50-59:

  1. Sinusitis (inflammation of sinus)

60+:

  1. Anxiety
  2. Apathy
  3. Weight increased
  4. Cardiac fibrillation (uncontrolled muscle contraction of heart)
  5. Cardiac output decreased
  6. Crush injury (compression of extremities or other parts of the body that causes muscle swelling and/or neurological disturbances)
  7. Haematoma (collection of blood outside the blood vessels)
  8. Malignant melanoma in situ (early stage of cancer in melanocyte)
  9. Road traffic accident
  10. Viral myocarditis (inflammation of heart muscle caused by viral infection)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 20.83%
  2. Renal Cell Carcinoma (a kidney cancer): 2 people, 8.33%
  3. Metastases To Lung (cancer spreads to lung): 2 people, 8.33%
  4. Drug Dependence: 2 people, 8.33%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent hfa and Zopiclone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atrovent hfa and Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atrovent hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atrovent hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and eszopiclone (the active ingredients of Atrovent hfa and Zopiclone, respectively), and Atrovent hfa and Zopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: